HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer

January 18, 2024

https://www.globenewswire.com/news-release/2024/01/18/2811402/0/en/HilleVax-Announces-Executive-Management-Appointment-of-Sean-McLoughlin-as-Chief-Operating-Officer.html

BOSTON, Jan. 18, 2024 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq:HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the appointment of Sean McLoughlin as Chief Operating Officer. As part of a planned transition in connection with Mr. McLoughlin’s appointment, Co-founder and current Chief Operating Officer Dr. Aditya Kohli will remain a full-time executive with the company as Chief Business Officer, where he will be responsible for business development and corporate strategy. 

Read more at globenewswire.com

Related news for (HLVX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.